md, mph, facp, facc, fccp, faha, fnkf, fnla, fcrsa€¦ · md, mph, facp, facc, fccp, faha, fnkf,...
TRANSCRIPT
TUESDAY, APRIL 24, 2018–5:30pm
Led by Peter A. McCulloughMD, MPH, FACP, FACC, FCCP, FAHA, FNKF, FNLA, FCRSABaylor Heart and Vascular Institute
New Insights into Lipids and Vascular
-
cation in patients with chronic kidney disease (CKD) and end stage renal
disease (ESRD). The epidemiology of both CKD and atherosclerosis
Discussion of the impact of lipid lowering therapy in cardiovascular
outcomes and the progression of CKD will be highlighted with the latest
clinical trial data.
RE
NA
L R
OU
ND
TAB
LE
SE
RIE
SRE
GIS
TER
NO
WRE
GIS
TER
NO
W
Dr. McCullough directs cardiovascular education and researchfor the Baylor Health Care System and is a Vice Chief ofMedicine at Baylor University Medical Center. He is an internationally recognized authority on the role of chronic kidney disease as a cardiovascular risk state with over 1000 publications.
After receiving a bachelor’s degree from Baylor University, he completed his medical degree as anAlpha Omega Alpha graduate from the University ofTexas Southwestern Medical School, his internal medicine residency at the University of Washington, cardiology fellowship at WilliamBeaumont Hospital, and master’s degree in public health at the University of Michigan.
Registration Now Open!
This program is intended for physicians (all specialties and primary care) and advanced practitioners. The evening’s Re-nal Roundtable program, including dinner, is complimentary to attendees but space is limited so registration is required.
RESERVATION REQUIRED Online: kidney.org/renalroundtable-kc or call JoAnna Rogers at 913.262.1551 ext. 473
Brio Tuscan Grill 502 Nichols Road Kansas City, MO 64112